These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37966402)

  • 1. Applications of Gene Therapy in Cardiomyopathies.
    Argiro A; Bui Q; Hong KN; Ammirati E; Olivotto I; Adler E
    JACC Heart Fail; 2024 Feb; 12(2):248-260. PubMed ID: 37966402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in gene therapy of dystrophic heart disease.
    Lai Y; Duan D
    Gene Ther; 2012 Jun; 19(6):678-85. PubMed ID: 22318092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.
    Fayssoil A; Nardi O; Orlikowski D; Annane D
    Heart Fail Rev; 2010 Jan; 15(1):103-7. PubMed ID: 19943106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dwarf Open Reading Frame (DWORF) Gene Therapy Ameliorated Duchenne Muscular Dystrophy Cardiomyopathy in Aged mdx Mice.
    Morales ED; Yue Y; Watkins TB; Han J; Pan X; Gibson AM; Hu B; Brito-Estrada O; Yao G; Makarewich CA; Babu GJ; Duan D
    J Am Heart Assoc; 2023 Feb; 12(3):e027480. PubMed ID: 36695318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.
    Bostick B; Shin JH; Yue Y; Wasala NB; Lai Y; Duan D
    J Mol Cell Cardiol; 2012 Aug; 53(2):217-22. PubMed ID: 22587991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of emerging molecular and genetic therapies on cardiopulmonary disease in Duchenne muscular dystrophy.
    McKim DA; Cripe TP; Cripe LH
    Pediatr Pulmonol; 2021 Apr; 56(4):729-737. PubMed ID: 33142052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical studies for gene therapy of Duchenne muscular dystrophy.
    Odom GL; Banks GB; Schultz BR; Gregorevic P; Chamberlain JS
    J Child Neurol; 2010 Sep; 25(9):1149-57. PubMed ID: 20498332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the smallest virus to the biggest gene: marching towards gene therapy for duchenne muscular dystrophy.
    Duan D
    Discov Med; 2006 Jun; 6(33):103-8. PubMed ID: 17234143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients.
    Duan D
    Hum Gene Ther; 2018 Jul; 29(7):733-736. PubMed ID: 29463117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice.
    Xu L; Lau YS; Gao Y; Li H; Han R
    Mol Ther; 2019 Aug; 27(8):1407-1414. PubMed ID: 31129119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for Duchenne muscular dystrophy: AAV leads the way.
    Judge LM; Chamberlain JS
    Acta Myol; 2005 Dec; 24(3):184-93. PubMed ID: 16629052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duchenne Muscular Dystrophy Mice and Men: Can Understanding a Genetic Cardiomyopathy Inform Treatment of Other Myocardial Diseases?
    Rafael-Fortney JA; Chadwick JA; Raman SV
    Circ Res; 2016 Apr; 118(7):1059-61. PubMed ID: 27034274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Trans-splicing adeno-associated viral delivery efficiently transduces the heart of adult mdx mouse, a model for duchenne muscular dystrophy.
    Ghosh A; Yue Y; Shin JH; Duan D
    Hum Gene Ther; 2009 Nov; 20(11):1319-28. PubMed ID: 19627234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD).
    Kawecka K; Theodoulides M; Hasoglu Y; Jarmin S; Kymalainen H; Le-Heron A; Popplewell L; Malerba A; Dickson G; Athanasopoulos T
    Curr Gene Ther; 2015; 15(4):395-415. PubMed ID: 26159373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.
    Duan D
    Hum Mol Genet; 2006 Oct; 15 Spec No 2(SPEC):R253-61. PubMed ID: 16987891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy.
    Ho PP; Lahey LJ; Mourkioti F; Kraft PE; Filareto A; Brandt M; Magnusson KEG; Finn EE; Chamberlain JS; Robinson WH; Blau HM; Steinman L
    Proc Natl Acad Sci U S A; 2018 Sep; 115(39):E9182-E9191. PubMed ID: 30181272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy for Hemophilia and Duchenne Muscular Dystrophy in China.
    Liu X; Liu M; Wu L; Liang D
    Hum Gene Ther; 2018 Feb; 29(2):146-150. PubMed ID: 29366352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical development on the frontier: gene therapy for duchenne muscular dystrophy.
    Asher DR; Thapa K; Dharia SD; Khan N; Potter RA; Rodino-Klapac LR; Mendell JR
    Expert Opin Biol Ther; 2020 Mar; 20(3):263-274. PubMed ID: 32031420
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.
    Seto JT; Ramos JN; Muir L; Chamberlain JS; Odom GL
    Curr Gene Ther; 2012 Jun; 12(3):139-51. PubMed ID: 22533379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.